DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more
Drugs by Name Drugs by Condition Drugs by Category Most Searched Ratings/Reviews Active Ingred's Alerts Adverse Events

Reminyl (Galantamine Hydrobromide) - FDA Alerts

Reminyl Rx
FDA Alerts Summary Description Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Clinical Pharmacology Other Rx Information Active Ingredients Adverse Event Reports
 

Reminyl News
News in Media Published Studies Curr't Clinical Trials


Nutrilib.com
A comprihensive source of nutritional information

FDA Alerts related to Reminyl (Galantamine)

FDA ALERT [3/2005]

FDA and other international health authorities are reviewing the safety of Razadyne after data from two clinical studies indicated that people taking the drug had a higher death rate than those taking a placebo (sugar pill). Based on this information, FDA has asked the manufacturer to revise the labeling. Please ask your healthcare provider if Razadyne is right for you.

This information reflects FDA’s preliminary analysis of data concerning this drug. FDA is considering, but has not reached a final conclusion about, this information. FDA intends to update this sheet when additional information or analyses become available.

For complete, up-to-date safety information by the FDA, see MedWatch

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008